139 related articles for article (PubMed ID: 23303460)
1. Plasma microRNA-21 is associated with tumor burden in cutaneous melanoma.
Saldanha G; Potter L; Shendge P; Osborne J; Nicholson S; Yii N; Varma S; Aslam MI; Elshaw S; Papadogeorgakis E; Pringle JH
J Invest Dermatol; 2013 May; 133(5):1381-4. PubMed ID: 23303460
[No Abstract] [Full Text] [Related]
2. Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma.
Armand-Labit V; Meyer N; Casanova A; Bonnabau H; Platzer V; Tournier E; Sansas B; Verdun S; Thouvenot B; Hilselberger B; Doncescu A; Lamant L; Lacroix-Triki M; Favre G; Pradines A
Acta Derm Venereol; 2016 Jan; 96(1):29-34. PubMed ID: 26039581
[TBL] [Abstract][Full Text] [Related]
3. The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker.
Kanemaru H; Fukushima S; Yamashita J; Honda N; Oyama R; Kakimoto A; Masuguchi S; Ishihara T; Inoue Y; Jinnin M; Ihn H
J Dermatol Sci; 2011 Mar; 61(3):187-93. PubMed ID: 21273047
[TBL] [Abstract][Full Text] [Related]
4. Sensitive detection of melanoma metastasis using circulating microRNA expression profiles.
Shiiyama R; Fukushima S; Jinnin M; Yamashita J; Miyashita A; Nakahara S; Kogi A; Aoi J; Masuguchi S; Inoue Y; Ihn H
Melanoma Res; 2013 Oct; 23(5):366-72. PubMed ID: 23863473
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a plasma-based melanoma biomarker suitable for clinical use.
Van Laar R; Lincoln M; Van Laar B
Br J Cancer; 2018 Mar; 118(6):857-866. PubMed ID: 29360813
[TBL] [Abstract][Full Text] [Related]
6. Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay.
Blokzijl A; Chen LE; Gustafsdottir SM; Vuu J; Ullenhag G; Kämpe O; Landegren U; Kamali-Moghaddam M; Hedstrand H
PLoS One; 2016; 11(4):e0154214. PubMed ID: 27110718
[TBL] [Abstract][Full Text] [Related]
7. Pigmented cutaneous lesions: the difficult case.
McGovern VJ
Pathol Annu; 1978; 13 Pt 2():415-42. PubMed ID: 748843
[No Abstract] [Full Text] [Related]
8. Circulating biomarkers in malignant melanoma.
Alegre E; Sammamed M; Fernández-Landázuri S; Zubiri L; González Á
Adv Clin Chem; 2015; 69():47-89. PubMed ID: 25934359
[TBL] [Abstract][Full Text] [Related]
9. A pilot study of chromosomal aberrations and epigenetic changes in peripheral blood samples to identify patients with melanoma.
Jakub JW; Grotz TE; Jordan P; Hunter E; Pittelkow M; Ramadass A; Akoulitchev A; Markovic S
Melanoma Res; 2015 Oct; 25(5):406-11. PubMed ID: 26225582
[TBL] [Abstract][Full Text] [Related]
10. Sclerosing nevus with pseudomelanomatous features and regressing melanoma with nevoid features.
Ferrara G; Amantea A; Argenziano G; Broganelli P; Cesinaro AM; Donati P; Pellacani G; Zalaudek I; Tomasini C
J Cutan Pathol; 2009 Aug; 36(8):913-5; author reply 916. PubMed ID: 19586505
[No Abstract] [Full Text] [Related]
11. A plasma microRNA biomarker of melanoma as a personalised assessment of treatment response.
van Laar RK; Lincoln MT; van Laar BJ
Melanoma Res; 2019 Feb; 29(1):19-22. PubMed ID: 30320629
[TBL] [Abstract][Full Text] [Related]
12. [Cutaneous melanoma associated with previous nevus].
Gutiérrez MP; Barengo M; Mainardi C; Garay I; Kurpis M; Ruiz Lascano A
Medicina (B Aires); 2009; 69(5):536-40. PubMed ID: 19897439
[TBL] [Abstract][Full Text] [Related]
13. Serum tryptase levels in melanoma patients: case-control study and review of the literature.
Paolino G; Moliterni E; Didona D; Cardone M; Lopez T; Garelli V; Richetta AG; Bottoni U; Cantisani C; Rossi A; Calvieri S
G Ital Dermatol Venereol; 2019 Feb; 154(1):18-25. PubMed ID: 28079340
[TBL] [Abstract][Full Text] [Related]
14. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions.
Zembowicz A; Yang SE; Kafanas A; Lyle SR
Arch Pathol Lab Med; 2012 Dec; 136(12):1571-9. PubMed ID: 22480223
[TBL] [Abstract][Full Text] [Related]
15. [Acral lentiginous melanoma: a slow growing tumor of the second finger].
Cellier M; Sirvain S; Fraisse T
Presse Med; 2010 Oct; 39(10):1100-2. PubMed ID: 20630700
[No Abstract] [Full Text] [Related]
16. Circulating miRNA expression analysis reveals new potential biomarkers for human cutaneous melanoma staging.
Sánchez-Sendra B; García-Giménez JL; González-Muñoz JF; Navarro L; Murgui A; Terrádez L; Pinazo I; Martin JM; Monteagudo C
J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):e126-e129. PubMed ID: 31710393
[No Abstract] [Full Text] [Related]
17. Nodular melanomas associated with nevi.
Manganoni AM; Farisoglio C; Gavazzoni F; Facchetti F; Zanotti F; Calzavara-Pinton P
J Am Acad Dermatol; 2010 Nov; 63(5):e97. PubMed ID: 20950735
[No Abstract] [Full Text] [Related]
18. Clinical significance of serum M30 and M65 levels in melanoma.
Tas F; Karabulut S; Serilmez M; Yildiz I; Sen F; Ciftci R; Duranyildiz D
Melanoma Res; 2013 Oct; 23(5):390-5. PubMed ID: 23812330
[TBL] [Abstract][Full Text] [Related]
19. Outcome of patients with de novo versus nevus-associated melanoma.
Lin WM; Luo S; Muzikansky A; Lobo AZ; Tanabe KK; Sober AJ; Cosimi AB; Tsao H; Duncan LM
J Am Acad Dermatol; 2015 Jan; 72(1):54-8. PubMed ID: 25440436
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms in melanoma.
Diaz-Cano SJ
N Engl J Med; 2006 Sep; 355(13):1395; author reply 1396. PubMed ID: 17005965
[No Abstract] [Full Text] [Related]
[Next] [New Search]
